ArticleAntimicrobial agents and chemotherapy2011

Raltegravir is a substrate for SLC22A6: a putative mechanism for the interaction between raltegravir and tenofovir.

Darren M Moss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.